Navigation Links
Pharmacyclics First to Announce Breakthrough Therapy Designation in Oncology from the U.S. Food and Drug Administration
Date:2/12/2013

versus placebo plus bendamustine and rituximab in subjects with newly diagnosed MCL, SHINE (MCL3002).
- A Phase II single-arm study of ibrutinib as a monotherapy in patients with MCL who received at least one prior rituximab-containing chemotherapy regimen and who progressed after bortezomib therapy, SPARK (MCL2001).
- A Phase II single-arm study of ibrutinib as monotherapy in patients with relapsed or refractory MCL (PCYC-1104).

Conference Call
Further updates will be provided during the upcoming quarterly conference call on February 14, 2013 at 4:30 p.m. EDT. To participate in the conference call, please dial 1-877-407-0778 for domestic callers and 1-201-689-8565 for international callers. To access the live audio broadcast or the subsequent archived recording, log on to http://ir.pharmacyclics.com/events.cfm. The archived version of the webcast will be available for 30 days on the Investor Relations section of the company's Web site at http://www.pharmacyclics.com.

About Mantle Cell Lymphoma
MCL is an aggressive type of B-cell non-Hodgkin lymphoma (NHL) that usually occurs in older adults. The disease typically begins in the lymph nodes but can spread to other tissues, such as bone marrow and liver. Ibrutinib targets the B-cell receptor pathway an important pathway in malignant B-cell growth and proliferation. In the United States there are approximately 5,000 new cases of MCL each year.

About Waldenstrom's macroglobulinemia
Waldenstrom's macroglobulinemia is rare type of lymphoma. The disease begins with a malignant change to the B-cell during its maturation so that it continues to reproduce more malignant B-cells resulting in an overproduction of monoclonal immunoglobulin M antibody (IgM). WM is a hematologic malignancy for which no established standard of care - or approved therapeutic exists. I
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Pharmacyclics Announces Date of Financial Results for Three and Six Months Ended December 31, 2012 and Conference Call
2. Pharmacyclics Reports Fourth Quarter and Full Year Fiscal 2012 Financial Results and Recent Developments
3. Pharmacyclics Announces Oral Presentations of Ibrutinib (PCI-32765) at the 17th Congress of the European Hematology Association
4. Pharmacyclics Announces Oral Presentations and Clinical Update of Ibrutinib (PCI-32765) at the 2012 Annual Meeting of the American Society of Clinical Oncology
5. Landauer, Inc. Reports Fiscal 2013 First Quarter Results
6. Misonix Reports Financial Results for First Half of Fiscal 2013
7. CareFusion Reports First Half Fiscal 2013 Results
8. Avanir Pharmaceuticals Reports Fiscal 2013 First Quarter Financial And Business Results
9. American Pacific Reports Fiscal 2013 First Quarter Results; Reaffirms Full Year Guidance
10. European patient registry in venous thromboembolism (VTE) - PREFER in VTE - enrols first patient
11. Neutronic Ear Introduces Worlds First Rechargeable-Powered Hearing Device
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... -- Securities lawyers at Dunnam & Dunnam ... SLXP ) in connection with a buyout ... encouraged to contact attorney Hamilton Lindley by clicking ... the shareholder value of the transaction. Under terms of ... per share in cash. At least one analyst has ...
(Date:2/27/2015)... -- Boston Scientific Corporation (NYSE: BSX ) is ... Conference on March 10 in Miami Beach ... vice president and chief financial officer, and Susie ... a 25-minute question and answer session regarding the company ... Following a 5-minute break, a question and answer session ...
(Date:2/27/2015)... 27, 2015 /CNW/ - Covalon Technologies Ltd. (the "Company" or ... announced financial results for its first quarter ended December ... ended December 31, 2014, revenue was $1,336,685. Operating expenses ... or $0.02 per share.  Covalon,s President ... very pleased with the significant progress we have made ...
Breaking Medicine Technology:Boston Scientific to Participate in the Barclays 2015 Annual Healthcare Conference 2Covalon Announces First Quarter Financial Results 2Covalon Announces First Quarter Financial Results 3
... TEL-AVIV, Israel , March 15, 2010 Cheetah Medical, a,worldwide leader in noninvasive hemodynamic and cardiac output ... and also included Robert,Bosch Venture Capital (RBVC), MVM Life Science Partners (MVM) and existing,investors. , ... ... ...
... With heart disease continuing to be the No. 1 cause of death in the U.S., Atherotech Inc. has ... company is expanding its disease management services with the goal of helping physicians reduce death and disability from heart disease. ... ... , ...
Cached Medicine Technology:Cheetah Medical Closes $20 Million Series B Financing 2Cheetah Medical Closes $20 Million Series B Financing 3Cheetah Medical Closes $20 Million Series B Financing 4Cheetah Medical Closes $20 Million Series B Financing 5Cheetah Medical Closes $20 Million Series B Financing 6Atherotech Recruits Top Experts in Fight Against Heart Disease 2Atherotech Recruits Top Experts in Fight Against Heart Disease 3Atherotech Recruits Top Experts in Fight Against Heart Disease 4Atherotech Recruits Top Experts in Fight Against Heart Disease 5Atherotech Recruits Top Experts in Fight Against Heart Disease 6
(Date:3/2/2015)... 2015 Regulatory Compliance Associates® Inc. ... regulatory and technical consulting, announces Mr. Seyed Khorashahi ... , Before joining RCA, Mr. Khorashahi had ... in all aspects of developing safety-critical medical devices. ... (Medtronic), Regulatory Compliance Associates Inc., Baxter Healthcare, and ...
(Date:3/2/2015)... The Alliance for Bangladesh Worker Safety today ... to serve as chief safety officer. In this role, ... Bangladesh and guide remediation efforts in all factories from ... that the Alliance continues to bring world-class expertise to ... workers,” said Alliance Independent Chair Ellen Tauscher. “His role ...
(Date:3/2/2015)... Final Cut Pro X plugin specialists ... Pixel Film Studios. , “The TranStatic Volume 2 plugin gives ... Austin, CEO of Pixel Film Studios. “TranStatic Volume 2 is ... X editors toolbox.” , With TranStatic Volume 2 users can ... static scrambling effects from Pixel Film Studios. Users have total ...
(Date:3/1/2015)... (PRWEB) March 02, 2015 As ... web works co-founders, Michael Burns and Carita Weaver, ... addition to working with the Southlake Chamber of ... i5 web works recently launched a website for ... , A primary communications tool for Hill’s campaign, ...
(Date:3/1/2015)... Adults who are not legally married ... or universal policies can now use the QuotesPros.com portal ... insurance companies for single adults can now be researched ... . , The rate plans that nationwide agencies are ... a number of life protection policies. The term, universal ...
Breaking Medicine News(10 mins):Health News:Regulatory Compliance Associates® Inc. Welcomes Seyed Khorashahi as Chief Operating Officer 2Health News:Alliance for Bangladesh Worker Safety Names New Chief Safety Officer 2Health News:Pixel Film Studios released the TranStatic Volume 2 plugin for Final Cut Pro X today 2Health News:Website Launched for Southlake, Texas Mayoral Candidate Laura Hill 2Health News:Best Life Insurance Companies for Single Adults Now Searchable at Insurance Website 2
... identified in the blood of chronic sinusitis sufferers that ... disease, researchers say. , They used a sophisticated research ... proteins and found among 96 chronic sinusitis patients a ... can diagnose this disease with a totally objective test ...
... will support nonprofit organizations that address health care ... access and priorities in a four-state ... Group, the largest,health insurer in the Northwest/ Intermountain region, ... transforming health care in,the United States. The Regence Foundation ...
... who,has served as chairman and CEO of global safety ... Bill Lambert, MSA president and chief operating,officer, will ring ... on,Tuesday, April 15. The ceremonial bell ringing comes approximately ... as part of a planned management,succession, and turn over ...
... ,Pet Parent,s Day, e-Cards available on petinsurance.com, ... (VPI),the nation,s oldest and largest provider of pet ... -- this year, April 27 -- as National,Pet ... celebrating pet,caregivers. In the traditional spirit of a ...
... cells drive breast cancer formation, researcher says , , MONDAY, ... suggest breast cancer may arise from stem cells and ... may be a key to treatment. , Researchers from ... gene can flip open two known cancer pathways in ...
... at Thomas Jefferson University in Philadelphia are inching ... might help prevent the spread of pancreatic cancer. ... type of pressure-lowering drug called an angiotensin receptor ... cell death. , In earlier work in the ...
Cached Medicine News:Health News:Potential blood test for chronic sinusitis identified 2Health News:Newly Launched Regence Foundation to Help Transform Health Care and Influence the Nationwide Health Care Debate 2Health News:MSA's John Ryan III and Bill Lambert to Ring Closing Bell at New York Stock Exchange on Tuesday 2Health News:MSA's John Ryan III and Bill Lambert to Ring Closing Bell at New York Stock Exchange on Tuesday 3Health News:Veterinary Pet Insurance Launches National Pet Parent's Day 2Health News:Stem Cell Marker Controls Pair of Key Cancer Pathways 2Health News:Blood pressure drugs halt pancreatic cancer cell growth, Jefferson researchers find 2
The S4 Spinal System has quickly gained a reputation for being the next generation in pedicle screw systems because of its exceptionally small size and high biomechanical strength....
... Diagnostics is a clinical reference ... treatment and monitoring of hemostatic ... a collaboration of four laboratory ... defined vision to deliver customizable ...
All-natural porcine collagen can be used in open or laparoscopic placement....
...
Medicine Products: